Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Gareth Morgan, MD, NYU Langone Medical Center
Videos
Role of Tumor Complexity and Microenvironment in the Development of Multiple Myeloma
11/02/2023

Featuring Gareth Morgan, MD

Featuring Gareth Morgan, MD
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Gareth Morgan, MD, examines the role of tumor complexity and microenvironment in the development of multiple myeloma.
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Gareth Morgan, MD, examines the role of tumor complexity and microenvironment in the development of multiple myeloma.
During the 2023 Lymphoma,...
11/02/2023
Lymphoma, Leukemia & Myeloma Network
Kenneth Anderson, MD, Dana-Farber Cancer Institute
Videos
New Targets on the Horizon for Multiple Myeloma Treatment
11/01/2023

Featuring Kenneth C. Anderson, MD

Featuring Kenneth C. Anderson, MD ...
At the 2023 Lymphoma, Leukemia & Myeloma Congress, Kenneth C. Anderson, MD, discussed existing and promising novel therapies for patients with multiple myeloma.
At the 2023 Lymphoma, Leukemia & Myeloma Congress, Kenneth C. Anderson, MD, discussed existing and promising novel therapies for patients with multiple myeloma.
At the 2023 Lymphoma, Leukemia &...
11/01/2023
Lymphoma, Leukemia & Myeloma Network
Kenneth Anderson, MD, Dana-Farber Cancer Institute
Videos
New Targets on the Horizon for Multiple Myeloma Treatment
11/01/2023

Featuring Kenneth C. Anderson, MD

Featuring Kenneth C. Anderson, MD ...
At the 2023 Lymphoma, Leukemia & Myeloma Congress, Kenneth C. Anderson, MD, discussed existing and promising novel therapies for patients with multiple myeloma.
At the 2023 Lymphoma, Leukemia & Myeloma Congress, Kenneth C. Anderson, MD, discussed existing and promising novel therapies for patients with multiple myeloma.
At the 2023 Lymphoma, Leukemia &...
11/01/2023
Lymphoma, Leukemia & Myeloma Network
Eric Padron, MD, Moffitt Cancer Center
Videos
Updates on the Treatment of Patients With Chronic Myelomonocytic Leukemia
10/24/2023

Featuring Eric Padron, MD

Featuring Eric Padron, MD
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Eric Padron, MD, discusses updates regarding managing and treating chronic myelomonocytic leukemia.
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Eric Padron, MD, discusses updates regarding managing and treating chronic myelomonocytic leukemia.
During the 2023 Lymphoma,...
10/24/2023
Lymphoma, Leukemia & Myeloma Network
Eric Padron, MD, Moffitt Cancer Center
Videos
Updates on the Treatment of Patients With Chronic Myelomonocytic Leukemia
10/24/2023

Featuring Eric Padron, MD

Featuring Eric Padron, MD
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Eric Padron, MD, discusses updates regarding managing and treating chronic myelomonocytic leukemia.
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Eric Padron, MD, discusses updates regarding managing and treating chronic myelomonocytic leukemia.
During the 2023 Lymphoma,...
10/24/2023
Lymphoma, Leukemia & Myeloma Network
Julie Vose, MD
Videos
Advances in Treatment Options for Patients With T-Cell Lymphoma
10/24/2023

Featuring Julie Vose, MD

Featuring Julie Vose, MD
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Julie Vose, MD, discusses advances in improving outcomes for patients with peripheral T-cell lymphoma.
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Julie Vose, MD, discusses advances in improving outcomes for patients with peripheral T-cell lymphoma.
At the Lymphoma, Leukemia &...
10/24/2023
Lymphoma, Leukemia & Myeloma Network
Julie Vose, MD
Videos
Advances in Treatment Options for Patients With T-Cell Lymphoma
10/24/2023

Featuring Julie Vose, MD

Featuring Julie Vose, MD
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Julie Vose, MD, discusses advances in improving outcomes for patients with peripheral T-cell lymphoma.
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Julie Vose, MD, discusses advances in improving outcomes for patients with peripheral T-cell lymphoma.
At the Lymphoma, Leukemia &...
10/24/2023
Lymphoma, Leukemia & Myeloma Network
Amer M. Zeidan, MBBS, MHS, Yale
Videos
Novel Treatment Options for Patients With Myelodysplastic Syndromes
10/24/2023

Featuring Amer Zeidan, MBBS, MHS 

Featuring Amer Zeidan, MBBS, MHS  ...
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Amer Zeidan, MBBS, MHS, provided insights into novel treatment updates for patients with high and low-risk MDS.
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Amer Zeidan, MBBS, MHS, provided insights into novel treatment updates for patients with high and low-risk MDS.
During the 2023 Lymphoma,...
10/24/2023
Oncology
Amer M. Zeidan, MBBS, MHS, Yale
Videos
Novel Treatment Options for Patients With Myelodysplastic Syndromes
10/24/2023

Featuring Amer Zeidan, MBBS, MHS 

Featuring Amer Zeidan, MBBS, MHS  ...
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Amer Zeidan, MBBS, MHS, provided insights into novel treatment updates for patients with high and low-risk MDS.
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Amer Zeidan, MBBS, MHS, provided insights into novel treatment updates for patients with high and low-risk MDS.
During the 2023 Lymphoma,...
10/24/2023
Oncology
Koen van Besien, MD
Videos
Benefit of AlloSCT for Patients With TP53 Mutations and Acute Myeloid Leukemia/Myelodysplastic Syndromes
03/13/2023
Koen W. van Besien, MD, recaps a debate in which he argued that patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) and TP53 mutations should undergo allogeneic stem cell transplantation.
Koen W. van Besien, MD, recaps a debate in which he argued that patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) and TP53 mutations should undergo allogeneic stem cell transplantation.
Koen W. van Besien, MD, recaps a...
03/13/2023
Oncology

Advertisement

Advertisement

About

For nearly 2 decades, the Lymphoma, Leukemia & Myeloma Congress (formerly the Lymphoma & Myeloma Congress) has been recognized around the world as the most respected forum for industry-leading hematologic research.

It’s where interdisciplinary specialists convene to explore the controversial and the complex, the emerging and the exciting, and discuss, debate, and discover along the way.

This program features 4 days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders.

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use